Funding Opportunities


VICTORIA’S SECRET GLOBAL FUND FOR WOMEN’S CANCERS 2022 CAREER DEVELOPMENT AWARD, IN PARTNERSHIP WITH PELOTONIA & AACR

Deadline: June 28, 2022
Go to grant website

The AACR aims to foster innovation in the understanding, prevention, interception, early detection, diagnosis, and treatment of breast and gynecologic cancers to eliminate health disparities and improve patient outcomes. The research proposed for funding may be in basic, translational, clinical, or population sciences. Proposals focused on research into the causes of cancer health disparities and approaches to achieve equity in outcomes and applicants belonging to racial or ethnic groups shown to be underrepresented in the cancer-related sciences workforce are especially encouraged.


Prevention and Early Detection Grants

Deadline: July 11, 2022
Go to grant website

For over 30 years, the Prevent Cancer Foundation has been funding research grants and fellowships that demonstrate potential for impact on cancer prevention/early detection. The goal of the Research Program is to provide funding for innovative projects expected to lead to future funding from other peer-reviewed sources. The grants and fellowships selection process utilizes a research proposal review system similar to that of the National Institutes of Health. 

For the 2022 cycle, we highly encourage proposals focused on melanoma prevention and early detection. 


Notice of Special Interest (NOSI): IMPROVE Initiative: Implementation Science to Advance Maternal Health and Maternal Health Equity

Deadline: July 17, 2022
Go to grant website

The Office of the Director of the National Institutes of Health (NIH) announces this new funding opportunity to advance the goals of the NIH Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE) Initiative. IMPROVE aims to understand the biological, behavioral, environmental, sociocultural, and structural factors that affect pregnancy-related and pregnancy-associated morbidity and mortality and build an evidence base for improved care and outcomes. The initiative promotes research to address health disparities associated with pregnancy-related and pregnancy-associated morbidity and mortality.

The purpose of this Notice of Special Interest (NOSI) is to stimulate dissemination and implementation research on innovative approaches built on evidence-based findings from foundational research on factors that contribute to maternal morbidity and mortality (MMM). This NOSI will support the development and implementation of strategies to inform integrated efforts involving policy and practice changes to improve preconception, pregnancy, perinatal, and postpartum care and advance maternal health and maternal health equity.


DOD-CDMRP Peer Reviewed Alzheimer's Research Program (PRARP)

Deadline: July 23, 2022
Go to grant website

The PRARP prioritizes research that will provide meaningful outcomes to support caregivers and persons with AD and ADRD, with a focus on partnership with those most impacted by these conditions. In addition, the PRARP strongly advocates for study population diversity, including but not limited to ethnic, cultural, socioeconomic, and health access factors. In addition to a focus on individual and care support, the PRARP seeks to support research focusing on the intersection of TBI-AD/ADRD, including understanding mechanisms, biomarkers, and risk factors associated with Veteran populations. The PRARP is interested in supporting research leading to treatment modalities that have near-term benefit. Mechanisms include: Accelerating Diagnostics Research Award; Investigator-Initiated Research Award; and Translational Research Award.  


Bioprinted Tissue Constructs for Obstetric, Gynecologic, and Pediatric Applications (R01 Clinical Trial Optional)

Deadline: July 28, 2022
Go to grant website

The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications that will utilize 3D bioprinting technologies to develop tissue constructs for long-term use that will adapt to the needs of growing children, and for obstetric and gynecological conditions. The overall goal of this initiative is to promote the clinical translation of bioprinted tissue constructs by helping to identify and working to overcome current barriers to preclinical product development, validation and verification. This will ultimately enable evidence generation for regulatory approval and human testing of mature bioprinted tissue constructs addressing the unmet needs of NICHD mission-relevant gynecologic, obstetric and pediatric diseases and disorders. Of note, this FOA is not intended for early stage, hypothesis validation of new bioprinted tissue constructs not yet mature for pursuing clinical translation or to support large scale clinical trials using bioprinted tissue constructs.


Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional)

Deadline: July 30, 2022
Go to grant website

The purpose of this announcement is to alert the community that the National Cancer Institute (NCI) plans to publish a Funding Opportunity Announcement (FOA) to invite applications for Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 activity code). This FOA supports the development of cancer-relevant technologies suitable for use in low- and middle-income countries (LMICs). Specifically, the FOA solicits applications for projects to adapt, apply, and validate existing or emerging technologies into a new generation of user-friendly, low-cost technologies for preventing, detecting, diagnosing, and/or treating cancers in people living in LMICs.

This Notice encourages investigators with expertise and insight into the areas of global oncology and global health technology research and development to begin developing responsive applications.

This funding opportunity is part of a broader NCI-sponsored Affordable Cancer Technologies (ACTs) Program.

The intended FOA will utilize the U01 Cooperative Agreement mechanism (Clinical Trial Optional).


USDA-FNS FY22 Community Innovation and Outreach (CIAO) Cooperative Agreement

Deadline: August 01, 2022
Go to grant website

FNS anticipates awarding up to $20 million to a Grantee (for the purpose of this RFA, this term is used in a general way to include cooperators who are awarded and manage cooperative agreements) to ultimately test the effectiveness of community outreach strategies in increasing WIC participation, especially among underserved populations within a community. This announcement of funding is for a one-time cooperative agreement with an accredited institution of higher education (college/university), nonprofit research entity, or other nonprofit organization. Only one application is allowed per institution.


Cooperative Agreement to Support an Evidence-Based Clinical Practice Guideline for the Management of Postoperative Pain After Surgeries in Obstetric Patients (U01) Clinical Trials Not Allowed

Deadline: August 04, 2022
Go to grant website

The U.S. Food and Drug Administration (FDA) seeks applications to develop, disseminate, implement, and evaluate an evidence-based Clinical Practice Guideline (CPG) for the management of postoperative pain in obstetric patients who have undergone surgeries, including but not limited to cesarean delivery, vaginal delivery, and appendectomy during pregnancy. Applicants must propose a comprehensive evidence-based plan that advances safe prescribing of opioid analgesics for obstetric patients with postoperative pain.


Implementation Research to Reduce Noncommunicable Disease (NCD) Burden in Low- and Middle-Income Countries (LMICs) and Tribal Nations During Critical Life Stages and Key Transition Periods (R01 Clinical Trial Optional)

Deadline: August 11, 2022
Go to grant website

The National Institutes of Health (NIH) participating Institutes and Centers (ICs), in collaboration with the Global Alliance for Chronic Diseases (GACD), invite applications for implementation research focused on addressing risk factors for common noncommunicable diseases (NCDs) in World Bank-defined low- and middle-income countries (LMICs) and American Indian/Alaska Native (AI/AN) Tribal Nation populations in the United States. This Funding Opportunity Announcement (FOA) supports innovative approaches to identifying, understanding, developing, and implementing strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, tools, policies, and guidelines. In addition, studies to advance dissemination and implementation research methods and measures into application are encouraged. Specifically, this FOA invites applications that propose interventions targeting critical life stages (e.g., infancy, childhood, adolescence, pregnancy, older adults) and key transitions between life stages to reduce health risk and/or enhance positive health and lifestyle behaviors.

All applications must be within the scope of the mission of one of the Institutes/Centers listed above (see "Components of Participating Organizations"). Applications will be accepted from US and World Bank-defined LMIC institutions only.


Enhancing Social Connectedness and Ameliorating Loneliness to Prevent and Treat SUD and Support Recovery (R21 - Clinical Trial Not Allowed)

Deadline: August 16, 2022
Go to grant website

This Funding Opportunity Announcement (FOA) encourages exploratory and developmental research to better understand the role of social connectedness and/or loneliness in prevention, treatment and recovery from substance use disorders (SUDs). Research may use a variety of approaches, including leveraging existing data sources, survey research, social network analysis, new methods development, feasibility research, etc. Outcomes of interest include any of the following: substance use initiation, escalation, SUD diagnosis, connection to treatment, and engagement or retention in treatment or recovery.


Research Coordinating Center to Support Climate Change and Health Community of Practice (U24 – Clinical Trial Not Allowed)

Deadline: August 26, 2022
Go to grant website

The National Institute of Environmental Health Science (NIEHS), in partnership with Fogarty International Center (FIC), National Institute of Minority Health and Health Disparities (NIMHD), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Mental Health (NIMH), National Institute of Nursing Research (NINR), National Heart Blood and Lung Institute (NHBLI) and National Institute of Allergy and Infectious Disease (NIAID) are leading an NIH-wide Climate Change and Health (CCH) Initiative with the goals of reducing the health threats posed by climate change across the lifespan, including by improving the health of people who are at increased risk from or disparately affected by climate change impacts, and to build health resilience among individuals, communities, Tribal Nations, and nations around the world, thereby addressing health equity. This Funding Opportunity Announcement (FOA) solicits applications from eligible institutions to develop a Research Coordinating Center (RCC) to support the development of an NIH CCH Community of Practice (COP) by managing and supporting current CCH research and capacity building efforts and supporting the expansion of the COP in the long term.


Notice of Intent to Publish a Funding Opportunity Announcement for the NIH HEAL Initiative: Preventing Opioid Misuse and other Drug Use by Intervening on Social Determinants (R01 Clinical Trials Optional)

Deadline: September 01, 2022
Go to grant website

NIDA, with other NIH Institutes and Centers (ICs), NIMHD and NIA , intend to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) to seek applications for research on the impact of prevention strategies that actively address social determinants and that intervene at multiple levels of influence to reduce the risk of opioid misuse, polysubstance use, or risky substance use.